HUNTINGTON'S DISEASE
Clinical trials for HUNTINGTON'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new HUNTINGTON'S DISEASE trials appear
Sign up with your email to follow new studies for HUNTINGTON'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Huntington's drug enters first human tests
Disease control Recruiting nowThis study tests a new medicine called RG6496 in people who carry the gene for Huntington's disease. The goal is to check if it is safe and how the body handles it. About 40 participants will receive either the drug or a placebo, with an option to continue treatment in an open-la…
Matched conditions: HUNTINGTON'S DISEASE
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
New spinal injection aims to slow Huntington's brain damage
Disease control Recruiting nowThis study tests a new drug called ALN-HTT02 in 66 adults with early-stage Huntington's disease. The drug is given as a single injection into the spine to see if it is safe and how it affects the body. Researchers will also measure levels of the harmful huntingtin protein in spin…
Matched conditions: HUNTINGTON'S DISEASE
Phase: PHASE1 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New PET tracer aims to reveal hidden protein clumps in Huntington's brains
Diagnosis Recruiting nowThis study tests a new radioactive tracer that may light up harmful protein clumps in the brains of people with Huntington's disease during a PET scan. Researchers will scan 27 adults (healthy volunteers and people with early-stage Huntington's) to see if the tracer works safely …
Matched conditions: HUNTINGTON'S DISEASE
Phase: EARLY_PHASE1 • Sponsor: CHDI Foundation, Inc. • Aim: Diagnosis
Last updated May 15, 2026 11:57 UTC
-
Massive spinal fluid study aims to unlock Huntington's disease mysteries
Knowledge-focused Recruiting nowThis study is collecting spinal fluid and blood samples from 2,500 people at different stages of Huntington's disease. The goal is to find biological markers that can help researchers develop new treatments. Participants include people with Huntington's, their family members, and…
Matched conditions: HUNTINGTON'S DISEASE
Sponsor: University College, London • Aim: Knowledge-focused
Last updated May 17, 2026 03:10 UTC